Abstract
It has been realized for many years that cancer has a genetic component and at the level of the cell it can be said to be a genetic disease. In 1914, Boveri suggested that an aberration in the genome might be responsible for the origin of cancer. This was subsequently supported by the evidence that cancer, or the risk of cancer, could be inherited; that mutagens could cause tumors in both animals and humans, and that tumors are monoclonal in origin, that is, the cells of a tumor all show the genetic characteristics of the original transformed cell. It is only in recent years that the involvement of specific genes has been demonstrated at the molecular level. Cancer cells contain many alterations wich accumulate as tumors develop. Understanding genetic pathways was considered to be, and still remains, the prerequisite for the development of molecular and pharmacological therapeutics to treat and prevent cancer. While researchers in the 20th century focused on the identification of genetic pathways, the beginning of the 21st century will need to focus on the interphase of normal physiology and cancer. Cancer is a disease of the organism, nor simply of abnormal cells. In order to study accurately the complex host-tumor interactions that occur during tumor development, it is necessary to perform experiments in an in vivo setting in which neoplasms emerge in the appropriate microenvironment. While studies in tissue culture cells permit the molecular dissection of pathways operative in a single cell, research in mice integrates the complexity of an organ and its different cell types with the dynamic physiological status of the animal.....
Current Genomics
Title: Overview Section: Genetics of Cancer: Away from the Beaten Track
Volume: 3 Issue: 4
Author(s): Isidro Sanchez-Garcia
Affiliation:
Abstract: It has been realized for many years that cancer has a genetic component and at the level of the cell it can be said to be a genetic disease. In 1914, Boveri suggested that an aberration in the genome might be responsible for the origin of cancer. This was subsequently supported by the evidence that cancer, or the risk of cancer, could be inherited; that mutagens could cause tumors in both animals and humans, and that tumors are monoclonal in origin, that is, the cells of a tumor all show the genetic characteristics of the original transformed cell. It is only in recent years that the involvement of specific genes has been demonstrated at the molecular level. Cancer cells contain many alterations wich accumulate as tumors develop. Understanding genetic pathways was considered to be, and still remains, the prerequisite for the development of molecular and pharmacological therapeutics to treat and prevent cancer. While researchers in the 20th century focused on the identification of genetic pathways, the beginning of the 21st century will need to focus on the interphase of normal physiology and cancer. Cancer is a disease of the organism, nor simply of abnormal cells. In order to study accurately the complex host-tumor interactions that occur during tumor development, it is necessary to perform experiments in an in vivo setting in which neoplasms emerge in the appropriate microenvironment. While studies in tissue culture cells permit the molecular dissection of pathways operative in a single cell, research in mice integrates the complexity of an organ and its different cell types with the dynamic physiological status of the animal.....
Export Options
About this article
Cite this article as:
Sanchez-Garcia Isidro, Overview Section: Genetics of Cancer: Away from the Beaten Track, Current Genomics 2002; 3 (4) . https://dx.doi.org/10.2174/1389202023350390
DOI https://dx.doi.org/10.2174/1389202023350390 |
Print ISSN 1389-2029 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5488 |
Call for Papers in Thematic Issues
Current Genomics in Cardiovascular Research
Cardiovascular diseases are the main cause of death in the world, in recent years we have had important advances in the interaction between cardiovascular disease and genomics. In this Research Topic, we intend for researchers to present their results with a focus on basic, translational and clinical investigations associated with ...read more
Deep learning in Single Cell Analysis
The field of biology is undergoing a revolution in our ability to study individual cells at the molecular level, and to integrate data from multiple sources and modalities. This has been made possible by advances in technologies for single-cell sequencing, multi-omics profiling, spatial transcriptomics, and high-throughput imaging, as well as ...read more
New insights on Pediatric Tumors and Associated Cancer Predisposition Syndromes
Because of the broad spectrum of children cancer susceptibility, the diagnosis of cancer risk syndromes in children is rarely used in direct cancer treatment. The field of pediatric cancer genetics and genomics will only continue to expand as a result of increasing use of genetic testing tools. It's possible that ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Nanoparticles and Immune Cells
Current Pharmaceutical Design Tumoricidal and Anti-Angiogenic Actions of Gamma-Linolenic Acid and Its Derivatives
Current Pharmaceutical Biotechnology Activation of Latent HIV-1 Expression by Protein Kinase C Agonists. A Novel Therapeutic Approach to Eradicate HIV-1 Reservoirs
Current Drug Targets Dendritic Cell-Based Immune Therapy in Liver Diseases
Current Immunology Reviews (Discontinued) Anti-Inflammatory and Anti-Neoplastic Actions of Resveratrol
Current Nutrition & Food Science Azoles: Mode of Antifungal Action and Resistance Development. Effect of Miconazole on Endogenous Reactive Oxygen Species Production in Candida albicans
Anti-Infective Agents in Medicinal Chemistry Applications of Gene Therapy to the Treatment of Chronic Pain
Current Gene Therapy The Unbiased Search of Biomarkers in Neurodegenerative Diseases
Current Pharmaceutical Biotechnology Some Remarks on Prediction of Protein-Protein Interaction with Machine Learning
Medicinal Chemistry Enhanced Antisense Oligonucleotide Delivery Using Cationic Liposomes Incorporating Fatty Acid-Modified Polyethylenimine
Current Pharmaceutical Biotechnology The Current Role and Therapeutic Targets of Vitamin D in Gastrointestinal Inflammation and Cancer
Current Pharmaceutical Design Preparation of Water-Soluble Albumin Loaded Paclitaxil Nanoparticles Using Emulsion-Solvent Evaporation Technique
Current Bioactive Compounds Bispecific Antibodies (bsAbs): Promising Immunotherapeutic Agents for Cancer Therapy
Protein & Peptide Letters Evaluation of Angiogenesis Process after Metformin and LY294002 Treatment in Mammary Tumor
Anti-Cancer Agents in Medicinal Chemistry Acknowledgements to Reviewers
Recent Patents on Anti-Cancer Drug Discovery Chemotherapeutic Targeting of Cell Death Pathways
Anti-Cancer Agents in Medicinal Chemistry Relevance of Multidrug Resistance Proteins on the Clinical Efficacy of Cancer Therapy
Current Drug Delivery Survey of the State of the Art in Biomaterials, Cells, Genes and Proteins Integrated into Micro- and Nanoscaffolds for Tissue Regeneration
Current Nanoscience Editorial (Thematic Issue: Potential Therapeutic Agents based on DNA Sequence- Selective Binding Substances)
Current Topics in Medicinal Chemistry Current Major Cancer Targets for Nanoparticle Systems
Current Cancer Drug Targets